Related Experiment Video
Updated: Oct 8, 2025
07:12
Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
Published on: August 2, 2021
3.7K
Treatment-induced mood switching in affective disorders
Siu Wa Tang1,2, Wayne H Tang2, Brian E Leonard2,3
1Department of Pharmacology and Therapeutics, University of California, Irvine, CA, USA.
Acta Neuropsychiatrica
|December 27, 2021
Summary
Mood switching in bipolar disorder patients can be triggered by drug treatments. This study examines the link between psychotropic drug pharmacology and mood state changes, referencing existing mood switching hypotheses.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Patients with mood disorders, especially bipolar disorder, frequently experience mood state transitions.
- Mood switching can occur spontaneously or be induced by pharmacological interventions.
- Understanding the mechanisms of mood switching is crucial for effective treatment.
Purpose of the Study:
- To investigate the relationship between psychotropic drug pharmacology and induced mood switching.
- To review existing hypotheses regarding the mechanisms of mood switching.
- To analyze how drug properties might influence mood state transitions in patients.
Main Methods:
- Literature review of psychotropic drug pharmacology.
- Analysis of reported incidents of drug-induced mood switching.
- Examination of various scientific hypotheses on mood switching mechanisms.
- Cross-referencing drug properties with observed mood state changes in animal models and human studies.
Main Results:
- Certain classes of psychotropic drugs are associated with a higher incidence of mood switching.
- Pharmacological properties, such as receptor binding profiles and neurotransmitter modulation, may correlate with mood switching potential.
- Hypotheses involving dopaminergic and serotonergic systems are frequently implicated in mood switching.
Conclusions:
- The pharmacology of psychotropic medications plays a significant role in mood switching episodes in mood disorder patients.
- Further research is needed to elucidate the precise neurobiological pathways underlying drug-induced mood switching.
- This understanding can inform the development of mood stabilizers with reduced propensity for inducing mood state transitions.
Related Concept Videos
01:24Mania and Antimanic Drugs: Overview
360
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
360
01:23Antidepressant Drugs: MAOIs and Other Agents
411
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
411
01:28Drug Therapy
114
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
114
01:26Psychosis: Goals of Pharmacotherapy
252
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
252
01:30Bipolar Disorder
164
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
164
01:28Psychosis and Antipsychotic Drugs: Overview
519
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
519